argenx Announces VYVGART SC Prefilled Syringe for Self-Injection in Chronic Inflammatory Demyelinating Polyneuropathy Authorized for Sale by Health Canada

The MarketWatch News Department was not involved in the creation of this content.-- VYVGART(R) SC is first and only neonatal Fc receptor blocker approved to treat CIDP -- Authoriz ...
Nasdaq

argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy

VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
Monthly Prescribing Reference

Self-Administration Option Approved for Xolair Prefilled Syringe

Xolair, an anti-immunoglobulin E antibody, is indicated for the treatment of moderate to severe persistent asthma, chronic idiopathic urticaria, and nasal polyps. The Food and Drug Administration (FDA ...
Monthly Prescribing Reference

Fentanyl Citrate Injection 100mcg/2mL Available in Ready-to-Use Prefilled Syringe

Credit: Fresenius Kabi. The 100mcg per 2mL presentation is offered in a manufacturer-prepared prefilled syringe. Fresenius Kabi has launched a 100mcg per 2mL presentation of Fentanyl Citrate Injection ...

VABYSMO® (faricimab injection) Pre-Filled Syringe Now Publicly Funded through Ontario Drug Benefit (ODB) Program

La Roche Limited (Roche Canada) is pleased to announce today that VABYSMO® (faricimab injection) Pre-Filled Syringe (PFS) is ...
Nasdaq

BD Expands Capacity for Advanced Prefillable Syringes and Enhances Injection Experience for the Next Generation of Biologics

LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...